BRAF V600E Expression by Immunohistochemistry in Colon Cancer and Clinico-pathologic Features Associated with BRAF-Mutated Colonic Cancers in Mexican Patients

被引:0
|
作者
Karla J. González-Colunga
Leonardo S. Lino-Silva
Rosa A. Salcedo-Hernández
Erika B. Ruiz-García
César Zepeda-Najar
机构
[1] Instituto Nacional de Cancerología,Surgical Pathology
[2] Instituto Nacional de Cancerología de México (Mexico’s National Cancer Institute),Gastrointestinal Pathology Division
[3] Instituto Nacional de Cancerología,Surgical Oncology
[4] Instituto Nacional de Cancerología,Medical Oncology
[5] Hospital Ángeles Tijuana,Surgical Oncology
来源
关键词
BRAF; Molecular pathology; Colon cancer; Immunohistochemistry; Diagnostic test;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:35 / 40
页数:5
相关论文
共 50 条
  • [41] Prediction of BRAF V600E variant from cancer gene expression data
    Kang, Jun
    Lee, Jieun
    Lee, Ahwon
    Lee, Youn Soo
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (11) : 4051 - +
  • [42] BRAF V600E is associated with the upregulation of CLDN1 in thyroid cancer
    Orozco, Andrea Ross
    Meraz, Eliakym Arambula
    Quiroz, Anette Roxana Gastelum
    Ortega, Fred Luque
    Alvarez, Edith Eunice Garcia
    Arrazola, Marco Alvarez
    Hernandez, Karla Lizbeth Morales
    Magallanes, Noemi Garcia
    CANCER RESEARCH, 2024, 84 (07)
  • [43] Identification of molecular determinants of vinorelbine resistance in BRAF(V600E) mutated chemorefractory metastatic colorectal cancer patients
    Vecchione, Loredana
    Beumer, Ines
    Mulero-Sanchez, Antonio
    Snel, Mireille
    Pietrantonio, Filippo
    Cremolini, Chiara
    Loupakis, Fotios
    Martinetti, Antonia
    Fuca', Giovanni
    Moretto, Roberto
    Fontanini, Gabriella
    Fassan, Matteo
    Lonardi, Sara
    Schirripa, Marta
    Keilholz, Ulrich
    Bernards, Rene'
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Immunohistochemistry as a quick screening method for clinical detection of BRAF(V600E) mutation in melanoma patients
    Chen, Qiongrong
    Xia, Chunjiao
    Deng, Yunte
    Wang, Mingwei
    Luo, Ping
    Wu, Changming
    Yue, Junqiu
    Fang, Na
    Wang, Manxiang
    Wei, Shaozhong
    TUMOR BIOLOGY, 2014, 35 (06) : 5727 - 5733
  • [45] Immunohistochemical Detection of Mutated BRAF V600E Supports the Clonal Origin of BRAF-Induced Thyroid Cancers Along the Spectrum of Disease Progression
    Ghossein, Ronald A.
    Katabi, Nora
    Fagin, James A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (08): : E1414 - E1421
  • [46] Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
    Schirosi, Laura
    Strippoli, Sabino
    Gaudio, Francesca
    Graziano, Giusi
    Popescu, Ondina
    Guida, Michele
    Simone, Giovanni
    Mangia, Anita
    BMC CANCER, 2016, 16
  • [47] Activity of EGFR inhibition in atypical (non-V600E) BRAF-mutated metastatic colorectal cancer
    Johnson, Benny
    Loree, Jonathan M.
    Morris, Van K.
    Dasari, Arvind
    Pant, Shubham
    Raghav, Kanwal Pratap Singh
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [48] Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
    Laura Schirosi
    Sabino Strippoli
    Francesca Gaudio
    Giusi Graziano
    Ondina Popescu
    Michele Guida
    Giovanni Simone
    Anita Mangia
    BMC Cancer, 16
  • [49] Mutation in BRAF V600E: A Poor Prognostic Marker in Stage III Colon Cancers With Deficient MMR?
    Emambux, Sheik
    Mouillet, Guillaume
    Tougeron, David
    JAMA ONCOLOGY, 2017, 3 (09) : 1284 - 1285